DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.
Epax CEO Ola Snove thinks the €2bn BASF and DSM buying frenzy that saw many major suppliers consolidated in their hands is ultimately a good thing for the €20bn+ sector – but its independence remains valued at Epax.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
Royal DSM has emphasised “business continuity” and “smooth integration” following the completion of its $CAD540m (€436m) buy-out of the world’s largest omega-3 fish oil supplier, Ocean Nutrition Canada (ONC), today.
DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.
A fish oil supplement enriched with DHA may benefit early communicative development in infants, says the first randomized controlled trial testing high dose omega-3 on brain development in non-premature infants
With the volume of omega-3 science tripling in 10 years, the world’s leading omega-3 trade group is working with international regulators to have that research reflected in authorised claims – especially in the EU and the US.
The dynamics of the algal omega-3 market are set to change over the next 18 months with the entrance of two new players both promising to trump the competition in the efficiency and sustainability stakes.
A new player is poised to enter the vegetarian omega-3 market with a production process it claims will enable it to make the long chain fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from algae at a fraction of the cost of rivals.
Martek expects sales of its algal-sourced omega-3s to food and drink manufacturers to grow in the double-digits each year for the next four to five years as it broadens its product range and gains access to new markets and customers post its takeover...
High doses of the omega-3 fatty acid DHA in baby formula or breast milk may have ‘modest, positive effects’ on the growth of the pre-term infants, including increased length, says a new study from Australia.
Martek Biosciences is to sell off the majority of its manufacturing plant in Winchester to animal health company Alltech as part of a restructuring plan, but will retain some R&D and limited production capacity at the site.
Omega-3 producer Martek Biosciences Corporation has signed a multi-year agreement to to fortify Feihe Dairy’s new premium infant formula and growing-up milk products with DHA and ARA for sale in China.
Martek is set to give greater focus to DHA (Docosahexaenoic Acid) products targeted at older adults after a study published this week confirmed the brain health benefits of DHA consumption for that segment of the population.
The USDA’s National Organic Program (NOP) is reviewing the approval for omega-3 fatty acid DHA and omega-6 fatty acid ARA to be included in infant formula or baby foods that are certified as organic because, it says, the ingredients have not received...
The first cooking oil fortified with the omega-3 fatty acid DHA is now available in China thanks to a new partnership between US company Martek Biosciences Corporation and local food manufacturer and trading group COFCO Food Sales & Distribution.
First quarter revenue for 2010 rose three percent to $89.8m at Maryland-based DHA specialist Martek Biosciences Corporation, with revenue jumping eight percent to $10.4m when costs associated with its acquisition of Amerifit Brands were discounted.
Illinois-based food multinational, Sara Lee, has made its first leap into the functional bakery, omega-3 space with a DHA-fortified white bread aimed at children that has been backed by the Disney Corporation.
Global omega-3 DHA leader Martek Biosciences Corporation has made a bold move into product manufacture with the $200m acquisition of Amerifit Brands, a company that specializes in women’s and digestive health products.